UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________________________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) of the

SECURITIES EXCHANGE ACT OF 1934

____________________________________

Date of Report (Date of earliest event reported): ~~February~~June 229, 2018

ALGAE RESOURCE HOLDINGS INC

(Exact Name of Registrant as Specified in Charter)

Nevada	333-199029	98-1190597
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

Suite 1609, Jie Yang Building, 271 Lockhart Road Wanchai, Hong Kong	n/a
Suite 1609, Jie Yang Building, 271 Lockhart Road, Wanchai, Hong Kong	N/A
(Address of principal executive offices)	(Zip code)
Registrant's telephone number, including area code:	Tel: +852 2989 0251 Fax: +852 2149 7094

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

~~Item~~Section 51.0201 ~~Departure~~- ofEntry ~~Directors~~into ora ~~Certain~~Material ~~Officers;~~Definitive ~~Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Agreement

On ~~February~~June 229, 2018, ~~the Board of~~ Algae Resource Holdings, Inc., a Nevada corporation (the "Company"), ~~accepted~~entered ~~the~~into ~~resignation~~a ofSecurities ~~Mr.~~Purchase ~~Daobing~~Agreement ~~Song~~(the as"Purchase ~~Chief~~Agreement") ~~Executive~~with ~~Officer,~~China ~~President,~~Undeveloped ~~Chief~~Area ~~Financial~~Investment ~~Officer,~~Fund ~~Treasurer~~Ltd. ("Purchaser"), ~~Secretary~~a ~~and~~company ~~Director~~owned ~~of the Company~~ and ~~appointed~~controlled Drby Mr. Chester Chak Yuen ~~Chan~~CHAN, aspursuant ~~Chief~~to ~~Executive~~which ~~Officer,~~the ~~President,~~Company ~~Chief~~agreed ~~Financial~~to ~~Officer,~~sell ~~Treasurer~~an aggregate of 3,000,000 ~~Secretary~~newly ~~and~~issued ~~Director~~shares of the Company's common stock, $0.001 Mrpar value per share (the "Common Stock") at a purchase price of $0.02 ~~Song~~per ~~has~~share ~~indicated~~(the ~~that~~"Private ~~his~~Placement"). ~~resignation~~The ~~was~~gross ~~not~~proceeds ~~due~~of the Private Placement of $60,000 is to ~~any~~be ~~differences~~used orfor ~~disagreements~~working ~~with~~capital. ~~the~~The ~~Company's~~Private ~~executive~~Placement ~~management~~closed oron ~~Board~~July 2, 2018. The Private Placement was approved by the non-interested members of ~~Directors~~the Company.

~~DIRECTOR~~The ~~BIOGRAPHY~~foregoing description of the Purchase Agreement is qualified in its entirety by reference to this Current Report on Form 8-K and incorporated herein by reference.

DrSection 3.02 ~~Chester~~- ~~Chak~~Unregistered ~~Yuen~~Sale ~~Chan~~of Equity Securities

~~Dr.~~The ~~Chester~~information ~~Chak~~set ~~Yuen~~forth ~~CHAN ("Dr. Chan"), aged 62, has worked~~ in ~~the~~Item ~~oil~~1.01 ~~and~~of ~~renewable~~this ~~energy~~Current ~~sector~~Report ~~for~~on ~~over~~Form 408-K ~~years.~~concerning ~~Dr.~~the ~~Chan~~offer ~~has~~and ~~extensive~~sale ~~business~~of ~~experience,~~the ~~academic~~shares ~~background~~of ~~and~~Common ~~business~~Stock ~~and~~to ~~technical~~the ~~network~~Purchasers ~~including~~pursuant ~~through~~to ~~his work in~~ the ~~community.~~Purchase ~~Over~~Agreement ~~the~~is ~~past~~incorporated 5herein ~~years,~~by Drreference. ~~Chan~~The ~~has~~shares ~~managed~~of VFCommon ~~Holdings~~Stock ~~Limited~~issued ~~a company that holds patents~~ and ~~formulas~~sold ~~for~~under the ~~Hong~~Purchase ~~Kong~~Agreement ~~and~~as ~~China~~described ~~markets~~in ~~for~~Item ~~extracting~~1.01 ~~high~~were ~~purity~~offered ~~Omega~~and 3sold ~~from~~by the ~~plant~~Company ~~for~~in ~~healthcare~~reliance ~~applications~~upon ~~and~~an ~~World~~exemption ~~Oil~~from ~~Recycling~~registration ~~System~~pursuant ~~Limited,~~to ~~which~~Section ~~focused~~4(a)(2) onof the ~~biomass~~Securities ~~energy~~Act ~~and~~of ~~biodiesel~~1933, ~~refinery~~as ~~program~~amended, and ~~environment-protection.~~Rule ~~The~~506(b) ~~Company~~of ~~acquired~~Regulation ~~100%~~D ~~interests in VF Holdings Limited on January 31, 2018~~thereunder.

Over the past 40 years, Dr. Chan has worked is a major subsidiary of Sinopec Group, a State-owned enterprise in China, in the 1980s. When China designated Shanghai's opening and development, Dr. Chan was appointed as Senior Executive for Shanghai Pudong Development Zone. Dr. Chan was also responsible for the building of a large 12 million tons oil refinery in China.

Exhibit No.	Description
10.1	Securities Purchase Agreement, dated June 29, 2018

In 1992, Dr. Chan became adjunct Professor in Dong Hua University, East China Normal University and Shanghai Jiaotong University for several years. After that, he came to Hong Kong and was the Managing Director of Lailay Group (SEHK code: 0456), a company listed on the Hong Kong Stock Exchange, that was in the oil refinery business. Dr. Chan managed large oil refineries with the supports from the professional team at AIG, France VICIN, UAE Imperial family member Sheikh Abdulla, Malaysia Petronas and China SINOPAC.

Dr. Chan was awarded Registered Consultant of Asian Development Bank in 2002. In 2002, he was appointed as Researcher & Head of an institute by Shanghai Academy of Social Science. He also spent time working with college professors and students to research and develop algae, including algae products and algal-based biofuel. In 2014, he was invited as a guest professor in Science College of Open University of Hong Kong.

Dr. Chan received his Master of Science and Bachelor of Science (BS) in Electrical Engineering from Dong Hua University in China and his PHD Honor in Engineering Management from Shanghai Jiao Tong University.

Dr. Chan is not an officer of any other United States reporting company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 8, 2018	ALGAE RESOURCE HOLDINGS INC.
Date: July 10, 2018	ALGAE RESOURCE HOLDINGS INC.
	By: /s/ Dr. Chester Chak Yuen Chan
	_________________________________
	Name: Dr. Chester Chak Yuen Chan
	Title: Secretary and Director

Filing Compare · Algae Resource Holdings Inc.